Skip to main content
Alzheimer's DiseaseGeneticsSleepCognitive functionBrain and nervesRadiationGeneticProcedureBehavioral

What this study is

The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.

What's being tested

  • DaTscan

    Intervention · RADIATION

    A functional imaging of the dopamine transporter using the radioligand [123I]FP-CIT

  • F18-AV-45

    Intervention · RADIATION

    A brain scan to to measure the extent of amyloid deposition

  • FDG-PET

    Intervention · RADIATION

    a brain scan measuring total and regional cerebral glucose metabolism wtih positron emission tomographs with 2-(18F)

  • APOE genotype

    Intervention · GENETIC

    10 ml of whole blood will be drawn and shipped to Athena Diagnostics for genetic testing.

  • Polysomnogram

    Intervention · PROCEDURE

    Overnight sleep study

  • Clinical Assessment

    Intervention · BEHAVIORAL

    Clinical assessments include cognitive, behavioral, and motor evaluations

Study details

Sponsor
Douglas Scharre
Conditions
Alzheimer's Disease · Lewy Body Dementia · Parkinson's Disease
Enrolling
76 people
Starts
2018-08-30
Est. completion
2027-12-31
Record
View on ClinicalTrials.gov ↗